1McCormack TT,Sims J,Eyre-Brook I,et al.Gastric lesions in portal hypertension:inflammatory gastritis or congestive gastropathy ? Gut,1985,26:1226-1232.
2Konturek PC,Bobrzynski A,Konturek SJ,et al.Epidermal growth factor and transforming growth factor alpha in duodenal ulcer and non-ulcer dyspepsia patients before and after Helicobacter pylorieradication.Scand J Gastroenterol,1998,33:143-151.
3Russo F,Messa C,Amati L,et al.The influence of Helicobacter pylorieradication on the gastric mucosal content of epidermal growth factor,transforming growth factor alpha,and their common recptor.Scand J Gastroenterol,1998,33:271-275.
4Ohta M,Yamaguchi S,Gotoh N,et al.Pathogenesis of portal hypertensive gastropathy:a clinical and experimental review.Surgery,2002,131 (suppl 1):S 165-170.
5Romano M,Meise KS,Suozzo R,et al.Regional distribution of transforming growth factor-alpha and epidermal growth factor in normal and portal hypertensive gastric mucosa in humans.Dig Dis Sci,1995,40:263-267.
6Hui WM,Chen BW,Kung AW,et al.Effect of epidermal growth factor on gastric blood flow in rats.Gastroenterology,1993,104:1605-1610.
